The healthcare industry is experiencing a significant shift with the integration of digital innovations in cold chain ...

The industry needs to embrace innovation with technology towards novel drug development to remain relevant in the marketplace.

Cybercriminals’ tactics have evolved to target sensitive data and disrupt research and development in the pharmaceutical ...

Novo Nordisk has acquired the global rights to United Laboratories’ triple-agonist weight-loss and diabetes drug in a deal ...

After threatening to impose “25% or higher” tariffs on foreign-made pharmaceuticals along with automobiles and semiconductors ...

Drug developers can now leverage large language models to draft regulatory documents, which they hope will shorten the time ...

Cassava Sciences said on Tuesday its Alzheimer's drug simufilam, which has been at the center of regulatory scrutiny, failed ...

The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take a look at where Charles River Laboratories International, Inc.

In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.